Zobrazeno 1 - 10
of 142
pro vyhledávání: '"Al Mamun Bhuyan A"'
Autor:
Rosi Bissinger, Polina Petkova-Kirova, Olga Mykhailova, Per-Arne Oldenborg, Elena Novikova, David A. Donkor, Thomas Dietz, Abdulla Al Mamun Bhuyan, William P. Sheffield, Marijke Grau, Ferruh Artunc, Lars Kaestner, Jason P. Acker, Syed M. Qadri
Publikováno v:
Cell Communication and Signaling, Vol 18, Iss 1, Pp 1-10 (2020)
Abstract Background Thrombospondin-1 (TSP-1), a Ca2+-binding trimeric glycoprotein secreted by multiple cell types, has been implicated in the pathophysiology of several clinical conditions. Signaling involving TSP-1, through its cognate receptor CD4
Externí odkaz:
https://doaj.org/article/7086c71dd11f4222a9579a9a93259a1b
Autor:
Abdulla Al Mamun Bhuyan, Florian Lang
Publikováno v:
Cellular Physiology and Biochemistry, Vol 51, Iss 5, Pp 1996-2009 (2018)
Background/Aims: The anaplastic lymphoma kinase (ALK) inhibitor alectinib is clinically used for the treatment of ALK positive non-small-cell lung cancer. At least in part the substance is effective by triggering suicidal death or apoptosis of tumor
Externí odkaz:
https://doaj.org/article/c52b4f4de69a4f03abff6b668a93811f
Publikováno v:
Molecular Biology Reports. 50:4253-4260
Publikováno v:
Cellular Physiology and Biochemistry, Vol 51, Iss 2, Pp 501-512 (2018)
Background/Aims: The taurine derivative Taurolidine is effective against diverse bacteria and tumor growth. In the treatment of cancer, the substance is effective in part by triggering suicidal death or apoptosis of tumor cells. The Taurolidine-induc
Externí odkaz:
https://doaj.org/article/8e0ca421c65548f0a2ab2644b31b76dd
Autor:
Basma Sukkar, Stefan Hauser, Lisann Pelzl, Zohreh Hosseinzadeh, Itishri Sahu, Tamer al-Maghout, Abdulla Al Mamun Bhuyan, Nefeli Zacharopoulou, Christos Stournaras, Ludger Schöls, Florian Lang
Publikováno v:
Cellular Physiology and Biochemistry, Vol 51, Iss 1, Pp 278-289 (2018)
Background/Aims: The neurodegenerative disease Chorea-Acanthocytosis (ChAc) is caused by loss-of-function-mutations of the chorein-encoding gene VPS13A. In ChAc neurons transcript levels and protein abundance of Ca2+ release activated channel moiety
Externí odkaz:
https://doaj.org/article/078d7e4617df442498d11d43d0b718c1
Publikováno v:
Cellular Physiology and Biochemistry, Vol 50, Iss 6, Pp 2283-2295 (2018)
Background/Aims: The sesquiterpene lactone Costunolide is effective against various disorders including inflammation and malignancy. The substance is effective in part by triggering suicidal death or apoptosis of tumor cells. Mechanisms involved incl
Externí odkaz:
https://doaj.org/article/4a642b9f79724bc2bb274b28de4006cb
Publikováno v:
Cellular Physiology and Biochemistry, Vol 47, Iss 4, Pp 1352-1364 (2018)
Background/Aims: The Hedgehog pathway disrupting drug sonidegib is used in the treatment of basal cell carcinoma. Side effects of sonidegib include anemia, which could result either from impaired erythropoiesis or from loss of erythrocytes e.g. due t
Externí odkaz:
https://doaj.org/article/10492b1b96e7491f84d3ed0f02500571
Autor:
Abdulla Al Mamun Bhuyan, Florian Lang
Publikováno v:
Cellular Physiology and Biochemistry, Vol 47, Iss 3, Pp 1259-1273 (2018)
Background/Aims: The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor afatinib is primarily utilized for the treatment of non-small cell lung carcinoma. The drug is at least partially effective by triggering suicidal tumor cell death
Externí odkaz:
https://doaj.org/article/2b8710b2b4f8470aaf8ec29e60c9fd61
Autor:
Hang Cao, Abdulla Al Mamun Bhuyan, Anja T. Umbach, Rosi Bissinger, Meinrad Gawaz, Florian Lang
Publikováno v:
Cellular Physiology and Biochemistry, Vol 43, Iss 6, Pp 2264-2276 (2017)
Background/Aims: The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor afatinib is used for the treatment of several malignancies. Afatinib is at least partially effective by triggering apoptosis of tumor cells. Platelets may similarl
Externí odkaz:
https://doaj.org/article/c051ca716ece4e7a85715f0b8662b89f
Publikováno v:
Cellular Physiology and Biochemistry, Vol 43, Iss 2, Pp 507-517 (2017)
Background/Aims: The anaplastic lymphoma kinase (ALK) inhibitor ASP3026 is in clinical development for the treatment of ALK expressing non-small cell lung carcinoma (NSCLC). ASP3026 is in part effective by inducing apoptosis of tumor cells. Erythrocy
Externí odkaz:
https://doaj.org/article/ac960705e5244b5d804c1474625247e8